[Imaging mass spectrometry: a new tool for the analysis of skin biopsy. Application in Fabry's disease]

Ann Pharm Fr. 2006 Sep;64(5):328-34. doi: 10.1016/s0003-4509(06)75325-1.
[Article in French]

Abstract

The advent of innovative techniques in mass spectrometry, especially in the area of imaging, prompted us to evaluate two promising techniques: secondary ion mass spectrometry (SIMS) and matrix-assisted laser desorption/ionization (MALDI) mass spectrometry. For this purpose, sections of cutaneous biopsies from patients affected by Fabry's disease and control patients were analyzed. In the course of this disease, two physiological glycosphingolipids [globotriasylceramide (Gb3) and the galabiosylceramide (Ga2)] accumulate in certain tissues owing to a catabolism failure. The ability of these techniques to localize sites of accumulation in body tissues and their capacity to identify the accumulated lipid structures by mass spectra were evaluated. Results demonstrated that these two techniques provide complementary information:-secondary ion mass spectrometry enabled precise localization of areas of accumulation with lateral resolution in the micrometer range;-the signal obtained with matrix-assisted laser desorption/ionization mass spectrometry was high enough to identify these structures according to their molecular weight.

Publication types

  • English Abstract

MeSH terms

  • Diagnostic Imaging*
  • Fabry Disease / diagnosis*
  • Fabry Disease / pathology*
  • Glycosphingolipids / chemistry
  • Humans
  • Mass Spectrometry*
  • Skin / chemistry*
  • Skin / pathology*
  • Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization

Substances

  • Glycosphingolipids